Clinical Trial Detail

NCT ID NCT01107665
Title Pazopanib and Paclitaxel as First-Line Treatment for Subjects With Unresectable Stage III and Stage IV Melanoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, Irvine

skin melanoma


Paclitaxel + Pazopanib

Age Groups: adult

No variant requirements are available.